|

PrEP Step
FDA advisory committee okays Truvada for HIV prevention toolbox.

DIY Testing
FDA advisory committee unanimously recommends in-home HIV assay for approval.

Bone Booster
Reclast increases bone density for at least 5 years in HIV study.

Conference Coverage
AIDSmeds reviews prevention, treatment and cure science reported in Seattle.

Print This
Currently approved HIV drugs at a glance.

Coinfection in Focus
Hep magazine features the ins and outs of battling hep C and HIV.
|
|

Persistence is Key
Gene-modified T cells live for a decade, without major risks, in HIV studies.

What's Not to "Like"?
Social network giant aims to reduce organ waiting lists.

The Road Ahead
Report maps HIV cure research goals and gaps.

Therapeutic Vaccines
A TAG activist on the role of therapeutic vaccines in cure research.

Older and Wiser
Experts draft new treatment recommendations for HIV-positive people over 50.

HIV Treatment for All
U.S. guidelines now recommend meds for all people with HIV, regardless of CD4 cell count.
|
|

Thumbs Up for the Quad
Gilead's 4-in-1 tablet gets advisory committee okay

FDA Says...
Don't mix Victrelis with HIV protease inhibitors.

A Piece of Me
Why and how HIV+ people should donate tissues and organs for research.

When to Start and What to Start With
Our revised, must-read lesson on beginning HIV treatment.

That's What He Said
Check out what everyone's talking about in the AIDSmeds Forums

HIV+? Start Here
Click here for a guided tour of all our easy-to-read treatment lessons.
|